Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
BBIO
$74.29
+0.03%
BBIO
· BridgeBio Pharma, Inc.
$74.29
+0.02 (+0.03%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$14.47B
Shares
194.80M
Volume · Nov 6
3.16M
Avg daily vol (3M)
2.7M
All webcasts
Earnings call · FY2024 Q1
BridgeBio Pharma, Inc. (BBIO) Q1 2024 Earnings Call
Revenue
$211.12M
+11461.9% YoY
Diluted EPS
-$0.20
Gross margin · derived Q4
99.7%
+35.4 pp YoY
Net income
-$36.16M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed May 2, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed May 2, 2024 · complete as-filed document